Abstract ADP-ribosylation factor 6 (Arf6), a member of small GTPases ADP-ribosylation
factor (Arf) family, expresses widely in mammalian cells and mainly regulates the functions …

Background Numerous studies have highlighted that long non-coding RNAs (lncRNAs) can
bind to microRNA (miRNA) sites as competing endogenous RNAs (ceRNAs), thereby …

Understanding the function of oral mucosal epithelial barriers is essential for a plethora of
research fields such as tumor biology, inflammation and infection diseases, microbiomics …

Brain metastases remain a major problem in patients with advanced non-small cell lung
cancer (NSCLC). The permeability of the blood–brain barrier (BBB) is highly increased …

Glioblastoma multiforme (GBM), the most aggressive and malignant glioma, has a poor
prognosis. Although patients with GBM are treated with surgery, chemotherapy, and …

Purpose: Because of disease heterogeneity, limited studies on effective chemotherapies
and therapeutic agents for advanced gastric cancer are available. Erythrocyte membrane …

Background Esophageal squamous cell carcinoma (ESCC) is one of the most common
malignant tumors worldwide and is characterized by activation of epithelial-mesenchymal …

The primary reasons for the treatment failure of patients with oral tongue squamous cell
carcinoma (OTSCC) are metastasis and tumor recurrence. Identifying the exact mechanisms …

The ADP-ribosylation factor 6 (Arf6) is a small GTPase that regulates endocytic recycling
processes in concert with various effectors. Arf6 controls cytoskeletal organization and …

Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by
ZEB1 via Modulating Wnt5a and Related Mechanisms - PMC Back to Top Skip to main content …